|
|
|
Insider
Information: |
Schuler Jack W |
Relationship: |
|
City: |
Lake Forest |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
27,956,178 |
|
Indirect Shares
|
61,134,751 |
|
|
Direct
Value |
$198,559,401 |
|
|
Indirect Value
|
$175,231,488 |
|
|
Total
Shares |
89,090,929 |
|
|
Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
54
|
96
|
Stock
price went up :
|
14
|
2
|
Stock
price went down : |
40
|
94
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-25.7%
|
-5,816.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 19 of 26
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2014-03-21 |
4 |
S |
$1.79 |
$1,143,164 |
D/D |
(638,639) |
6,165,261 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
10% Owner |
|
2019-10-25 |
4 |
B |
$1.20 |
$3,076,500 |
I/I |
2,563,750 |
6,217,345 |
1.5 |
- |
|
AWH |
Aspira Womens Health Inc |
10% Owner |
|
2013-12-19 |
4 |
OE |
$1.46 |
$5,920,529 |
D/D |
4,055,157 |
6,673,029 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2014-03-20 |
4 |
S |
$1.90 |
$219,435 |
D/D |
(115,492) |
6,803,900 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2014-03-19 |
4 |
S |
$1.91 |
$836,809 |
D/D |
(438,120) |
6,919,392 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2024-01-23 |
4 |
A |
$0.00 |
$0 |
I/I |
1,156,069 |
6,949,694 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2012-03-02 |
4 |
B |
$3.33 |
$2,653,754 |
D/D |
796,923 |
6,954,144 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2013-08-20 |
4 |
B |
$1.45 |
$159,518 |
D/D |
110,005 |
7,064,149 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2013-08-21 |
4 |
B |
$1.40 |
$278,961 |
D/D |
199,586 |
7,263,735 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2013-08-22 |
4 |
B |
$1.36 |
$127,565 |
D/D |
93,777 |
7,357,512 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-11-01 |
4 |
B |
$2.80 |
$9,010,000 |
D/D |
3,217,857 |
7,780,721 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-11-08 |
4 |
B |
$4.00 |
$27,200 |
D/D |
6,800 |
7,787,521 |
2.37 |
- |
|
SLNO |
Soleno Therapeutics Inc |
10% Owner |
|
2022-03-31 |
4 |
B |
$0.00 |
$0 |
I/I |
4,000,000 |
7,911,804 |
1.42 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2013-03-06 |
4 |
A |
$0.00 |
$0 |
I/I |
8,043,004 |
8,043,004 |
0 |
- |
|
BDSX |
Biodesix Inc |
Director |
|
2021-12-30 |
4 |
B |
$4.35 |
$9,999,998 |
I/I |
2,298,850 |
8,463,164 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2024-05-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,560,694 |
8,510,388 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2013-08-12 |
4 |
A |
$8.04 |
$5,166,753 |
I/I |
642,631 |
8,685,635 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2013-08-14 |
4 |
B |
$8.04 |
$3,321,244 |
I/I |
413,090 |
9,098,725 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2013-08-15 |
4 |
B |
$7.72 |
$248,955 |
I/I |
32,248 |
9,130,973 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2013-08-16 |
4 |
B |
$8.00 |
$369,968 |
I/I |
46,246 |
9,177,219 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2013-08-19 |
4 |
B |
$7.97 |
$6,376 |
I/I |
800 |
9,178,019 |
2.17 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2013-10-28 |
4 |
B |
$12.26 |
$142,302 |
I/I |
11,500 |
9,189,519 |
2.25 |
- |
|
HNSN |
Hansen Medical Inc |
Director |
|
2013-08-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,505,546 |
|
- |
|
SLNO |
Soleno Therapeutics Inc |
10% Owner |
|
2021-05-18 |
4 |
S |
$1.03 |
$42,456 |
I/I |
(41,195) |
9,707,848 |
0 |
% |
|
SLNO |
Soleno Therapeutics Inc |
10% Owner |
|
2021-05-05 |
4 |
S |
$1.14 |
$283,149 |
I/I |
(248,115) |
9,749,043 |
0 |
% |
|
634 Records found
|
|
Page 19 of 26 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|